Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 70

Results For "RSE"

1709 News Found

Bayer aims to enhance performance and regain strategic flexibility by 2026
News | March 06, 2024

Bayer aims to enhance performance and regain strategic flexibility by 2026

Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis


Dr Sheth's launches 'Healthy India Initiative’ with Doctors For You
Healthcare | March 06, 2024

Dr Sheth's launches 'Healthy India Initiative’ with Doctors For You

Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers


Sumitomo Corporation launches new refrigerated ocean transportation service
Supply Chain | March 05, 2024

Sumitomo Corporation launches new refrigerated ocean transportation service

Connecting new production and consumption areas of chilled food by low-carbon transportation services


Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease
Clinical Trials | March 03, 2024

Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease

Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg


Pfizer Oncology hosts innovation day
News | March 01, 2024

Pfizer Oncology hosts innovation day

Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth


Bajaj Healthcare enters into definitive CDMO Agreement for 15 APIs with UK/EU customers
News | February 29, 2024

Bajaj Healthcare enters into definitive CDMO Agreement for 15 APIs with UK/EU customers

BHL will undertake the development and supply of these molecules


Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows achieved groundbreaking results in liver disease due to MASH
Clinical Trials | February 28, 2024

Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows achieved groundbreaking results in liver disease due to MASH

Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis


NIA signs MoU with Department of Thai Traditional and Alternative Medicine
Policy | February 28, 2024

NIA signs MoU with Department of Thai Traditional and Alternative Medicine

MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine